
Region:Global
Author(s):Shivani Mehra
Product Code:KROD11149
December 2024
91

By Product Type: The veterinary molecular diagnostics market is segmented by product type into instruments, kits and reagents, and software and services. Kits and reagents hold a dominant market share due to their widespread use in diagnostic procedures and the continuous development of advanced reagents that enhance test accuracy and efficiency.

By Region: The market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads the market, driven by factors such as advanced veterinary healthcare infrastructure, high pet ownership rates, and significant investments in research and development.

The veterinary molecular diagnostics market is characterized by the presence of several key players who contribute to its growth and development. The table below provides an overview of five major companies in the market
|
Company Name |
Establishment Year |
Headquarters Location |
Product Portfolio |
Annual Revenue (USD Billion) |
Number of Employees |
Global Presence |
Recent Developments |
Strategic Initiatives |
|
IDEXX Laboratories, Inc. |
1983 |
Westbrook, USA |
||||||
|
Thermo Fisher Scientific Inc. |
1956 |
Waltham, USA |
||||||
|
Zoetis Inc. |
1952 |
Parsippany, USA |
||||||
|
QIAGEN N.V. |
1984 |
Venlo, Netherlands |
||||||
|
bioMrieux SA |
1963 |
Marcy-l'toile, France |
Market Growth Drivers
Market Challenges:
Over the next five years, the global veterinary molecular diagnostics market is expected to experience significant growth. This expansion is driven by continuous advancements in diagnostic technologies, increasing awareness of animal health, and the rising prevalence of zoonotic diseases. Additionally, the integration of artificial intelligence and machine learning in diagnostic tools is anticipated to enhance the accuracy and efficiency of veterinary diagnostics, further propelling market growth.
Market Opportunities:
|
By Product Type |
Instruments |
|
By Technology |
Polymerase Chain Reaction (PCR) |
|
By Application |
Infectious Diseases |
|
By Animal Type |
Companion Animals |
|
By Region |
North America |
Definition and Scope
Market Taxonomy
Market Growth Rate
Market Segmentation Overview
Historical Market Size
Year-On-Year Growth Analysis
Key Market Developments and Milestones
Growth Drivers
Rising Incidence of Zoonotic Diseases
Technological Advancements in Molecular Diagnostics
Increasing Pet Ownership and Expenditure
Expansion of Livestock Industry
Market Challenges
High Cost of Diagnostic Instruments
Lack of Skilled Veterinary Professionals
Regulatory Hurdles
Opportunities
Emerging Markets in Developing Regions
Integration of AI and Machine Learning in Diagnostics
Development of Point-of-Care Testing Solutions
Trends
Adoption of PCR and Next-Generation Sequencing Technologies
Shift Towards Personalized Veterinary Medicine
Growth in Companion Animal Diagnostics
Government Regulations
Animal Health Surveillance Programs
Veterinary Diagnostic Device Approvals
International Trade Regulations Affecting Veterinary Products
SWOT Analysis
Stakeholder Ecosystem
Porters Five Forces Analysis
Competitive Landscape
By Product Type (Value %)
Instruments
Kits and Reagents
Software and Services
By Technology (Value %)
Polymerase Chain Reaction (PCR)
Microarray
DNA Sequencing
Others
By Application (Value %)
Infectious Diseases
Genetic Disorders
Oncology
Others
By Animal Type (Value %)
Companion Animals
Dogs
Cats
Horses
Others
Livestock Animals
Cattle
Swine
Poultry
Others
By Region (Value %)
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Detailed Profiles of Major Companies
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
Zoetis Inc.
QIAGEN N.V.
bioMrieux SA
Heska Corporation
Neogen Corporation
Virbac
Agfa-Gevaert Group
Veterinary Molecular Diagnostics, Inc.
Novacyt Group
Bionote, Inc.
Randox Laboratories Ltd.
Abaxis, Inc.
VCA Inc.
Cross Comparison Parameters
Number of Employees
Headquarters Location
Year of Inception
Annual Revenue
Product Portfolio
Market Share
Recent Developments
Strategic Initiatives
Market Share Analysis
Strategic Initiatives
Mergers and Acquisitions
Investment Analysis
Venture Capital Funding
Government Grants
Private Equity Investments
Veterinary Diagnostic Device Regulations
Compliance Requirements
Certification Processes
Future Market Size Projections
Key Factors Driving Future Market Growth
By Product Type (Value %)
By Technology (Value %)
By Application (Value %)
By Animal Type (Value %)
By Region (Value %)
Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) Analysis
Customer Cohort Analysis
Marketing Initiatives
White Space Opportunity Analysis
Disclaimer Contact UsThe initial phase involves constructing an ecosystem map encompassing all major stakeholders within the global veterinary molecular diagnostics market. This step is underpinned by extensive desk research, utilizing a combination of secondary and proprietary databases to gather comprehensive industry-level information. The primary objective is to identify and define the critical variables that influence market dynamics.
In this phase, we compile and analyze historical data pertaining to the global veterinary molecular diagnostics market. This includes assessing market penetration, the ratio of marketplaces to service providers, and the resultant revenue generation. Furthermore, an evaluation of service quality statistics is conducted to ensure the reliability and accuracy of the revenue estimates.
Market hypotheses are developed and subsequently validated through computer-assisted telephone interviews (CATIs) with industry experts representing a diverse array of companies. These consultations provide valuable operational and financial insights directly from industry practitioners, which are instrumental in refining and corroborating the market data.
The final phase involves direct engagement with multiple diagnostic equipment manufacturers to acquire detailed insights into product segments, sales performance, consumer preferences, and other pertinent factors. This interaction serves to verify and complement the statistics derived from the bottom-up approach, thereby ensuring a comprehensive, accurate, and validated analysis of the global veterinary molecular diagnostics market.
The global veterinary molecular diagnostics market is valued at approximately USD 323.63 million, based on a five-year historical analysis.
Challenges include the high cost of diagnostic instruments, a lack of skilled veterinary professionals, and regulatory hurdles that can impede the swift adoption of new technologies.
Key players in the market include IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., Zoetis Inc., QIAGEN N.V., and bioMrieux SA. These companies dominate due to their extensive product portfolios, global presence, and continuous investment in research and development.
The market is propelled by factors such as the rising incidence of zoonotic diseases, technological advancements in molecular diagnostics, increasing pet ownership, and the expansion of the livestock industry.
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.